Prolongation of allograft survival by 1,25-dihydroxyvitamin D3

Transplantation

Volumn 66, Issue 7, 1998, Pages 824-828

  Hullett, Debra A ^a   Cantorna, Margherita T ^a,b   Redaelli, Claudio ^a,c   Humpal Winter, Jean ^a   Hayes, Colleen E ^a   Sollinger, Hans W ^a   Deluca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

19 NOR 1,25 DIHYDROXYVITAMIN D2; CALCITRIOL; CALCIUM; CYCLOSPORIN A; ERGOCALCIFEROL DERIVATIVE; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VASCULARIZATION; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; CALCITRIOL; CYCLOSPORINE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HYPERCALCEMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED STRAINS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032532524     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810150-00002     Document Type: Article

References (18)

1. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocrine Rev 1995; 16: 200.
2. 3. J Cell Biochem 1992; 49: 26.
3. 3 reversibly blocks the progression of relapsing encephalomyelitis: a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 7861.
4. 3 prevents and ameliorates symptoms in two experimental models of human arthritis. J Nutr 1998; 128: 68.
5. 16-cholecalciferol. Transplantation 1991; 54: 762.
6. 3 prolongs allograft rat cardiac allograft survival. In: Norman AW, Schaefer K, Grigoleit H-G, v. Herrath D, eds. Molecular, cellular and clinical endocrinology. Berlin: Walter de Gruyter, 1988: 334.
7. Johnsson C, Binderup L, Tufveson G. Immunosuppression with vitamin D analogue, MC1288, in experimental transplantation. Transplant Proc 1996; 28: 888.
8. Balany G, Morris RI, Babany I, Kates RE. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model application to cyclosporin. J Pharmacol Exp Ther 1988; 244: 259.
9. Kawamura T, Hullett DA, Suzuki Y, Bechstein WO, Allison AM, Sollinger HW. Enhancement of allograft survival by combination RS-61443 and DUP-785. Therapy Transplant 1993; 55: 691.
10. SAS Institute, Inc. SAS/STAT User's Guide. Version 6, Fourth edition, vol. 142. Cary, NC, 1989.
11. 3 attenuates the expression of murine lupus of MRL/1 mice. Autoimmunity 1992; 12: 143.
12. 3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990; 54: 53.
13. 3 KH1060. Endocrinology 1995; 136: 866.
14. Morgan JW, Morgan DM, Lasky SR, Ford D, Kouttab N, Maizel AL. Requirements for induction by vitamin D-mediated gene regulation in normal human B lymphocytes. J Immunol 1996; 157: 2900.
15. 3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 1991; 94: 589.
16. 3. J Clin Invest 1987; 49: 1659.
17. 3. Cell Immunol 1989; 118: 328.
18. 3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 1992; 149: 400.